0 Comments
0 Shares
205 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
How CD47 Antibody Therapies Are Advancing Cancer Immunotherapy, Autoimmune Disease Treatment, and Personalized MedicineThe global leukocyte surface antigen CD47 antibody market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced therapeutic solutions to address the rising incidence of cancer and improve patient outcomes. The market was valued at USD 1.3 billion in 2025 and is projected to reach USD 3.5 billion by 2035, growing at a CAGR of 10.6%. The...0 Comments 0 Shares 51 Views 0 Reviews
-
The Precision Medicine Era: How Rheumatoid Arthritis Biologics and Autoimmune Disease Treatment Are Transforming Patient LivesThe introduction of Rheumatoid arthritis biologics represented a seismic shift in Autoimmune disease treatment. These are not just drugs; they are advanced therapies developed using living cells, designed to target specific proteins and pathways involved in the inflammatory process of RA. This targeted approach offers a level of precision previously unattainable, allowing...0 Comments 0 Shares 328 Views 0 Reviews
-
Autoimmune Polyglandular Syndrome Type 1 Market InsightsAutoimmune Polyglandular Syndrome Type 1 (APS-1) is a rare inherited autoimmune disorder characterized by the dysfunction of multiple endocrine glands, resulting in chronic health complications that require lifelong medical management. Growing awareness of rare autoimmune diseases, advancements in diagnostic technologies, and increasing investments in targeted therapies are contributing...0 Comments 0 Shares 1K Views 0 Reviews
-
Connective Tissue Disease Market Forecast: Emerging Therapies and Growth OpportunitiesConnective tissue diseases (CTDs) represent a group of autoimmune and inflammatory disorders that affect the body's connective tissues, including joints, skin, blood vessels, muscles, and internal organs. Rising awareness of autoimmune disorders, advancements in diagnostic technologies, increasing healthcare spending, and the introduction of innovative biologic therapies are contributing...0 Comments 0 Shares 1K Views 0 Reviews